EZH2 modulates mRNA splicing and exerts part of its oncogenic function through repression of splicing factors in CML.

Leukemia · 2025 · PMC11879851 · PMID 39774797

Europe PMC DOI

hedged sentence

0.0934

closest p · 1.9× alpha

0.0934

boldest claim

The sentences

did not reach statistical significancep = 0.0934so close (0.05 < p ≤ 0.1)

CELF2 , was included in the set of down-regulated genes, but the difference between CML and healthy donors did not reach statistical significance (Fig. 6E , p = 0.0934).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.